Showing results (221-230 of 605) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|June 14, 2019
Long-Term Inpatient Hospital Utilisation and Costs (2007-2008 to 2015-2016) for Publicly Waitlisted Bariatric Surgery Patients in an Australian Public Hospital System Based on Australia's Activity-Based Funding ModelJulie A Campbell, Martin Hensher, Daniel Davies, et al.
Pharmacoeconomics - Open|August 29, 2018
Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup ElectrodesAnne Sohrt, Anders Mærkedahl, William V Padula
Pharmacoeconomics - Open|June 27, 2019
Using Time Trade-Off Methods to Elicit Short-Term Utilities Associated with Treatments for Bulbar Urethral StrictureJing Shen, Matthew Breckons, Luke Vale, et al.
Pharmacoeconomics - Open|June 28, 2019
Correction to: A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South AfricaLetlhogonolo Makhele, Moliehi Matlala, Mncengeli Sibanda, et al.
Pharmacoeconomics - Open|July 8, 2019
Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health DataAsh Bullement, Samuel Thomas McMordie, Anthony James Hatswell, et al.
Pharmacoeconomics - Open|July 12, 2019
Buccal Midazolam Solution for the Management of Prolonged Acute Convulsive Seizures: A Cost AnalysisCatherine Ludwig, Lauri Fisher
Pharmacoeconomics - Open|April 23, 2021
Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility AnalysisHansoo Kim, Greg Cook, Stephen Goodall, et al.
Pharmacoeconomics - Open|April 3, 2023
Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in ScotlandAmy Dymond, Will Green, Mary Edwards, et al.
Pharmacoeconomics - Open|August 12, 2020
The Value of a New Diagnostic Test for Prostate Cancer: A Cost-Utility Analysis in Early Stage of DevelopmentAdam Fridhammar, Ulrika Axelsson, Ulf Persson, et al.
Pharmacoeconomics - Open|May 20, 2023
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System PerspectiveCesarius Singgih Wahono, Laniyati Hamijoyo, Yuriawati Hendrawan, et al.
Pageof 61